1. Home
  2. FULC vs MBI Comparison

FULC vs MBI Comparison

Compare FULC & MBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • MBI
  • Stock Information
  • Founded
  • FULC 2015
  • MBI 1973
  • Country
  • FULC United States
  • MBI United States
  • Employees
  • FULC N/A
  • MBI N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • MBI Property-Casualty Insurers
  • Sector
  • FULC Health Care
  • MBI Finance
  • Exchange
  • FULC Nasdaq
  • MBI Nasdaq
  • Market Cap
  • FULC 372.2M
  • MBI 377.2M
  • IPO Year
  • FULC 2019
  • MBI 1987
  • Fundamental
  • Price
  • FULC $7.44
  • MBI $7.08
  • Analyst Decision
  • FULC Buy
  • MBI Buy
  • Analyst Count
  • FULC 8
  • MBI 1
  • Target Price
  • FULC $7.13
  • MBI $8.00
  • AVG Volume (30 Days)
  • FULC 398.4K
  • MBI 455.5K
  • Earning Date
  • FULC 11-12-2025
  • MBI 11-06-2025
  • Dividend Yield
  • FULC N/A
  • MBI N/A
  • EPS Growth
  • FULC N/A
  • MBI N/A
  • EPS
  • FULC N/A
  • MBI N/A
  • Revenue
  • FULC N/A
  • MBI $108,000,000.00
  • Revenue This Year
  • FULC N/A
  • MBI N/A
  • Revenue Next Year
  • FULC N/A
  • MBI N/A
  • P/E Ratio
  • FULC N/A
  • MBI N/A
  • Revenue Growth
  • FULC 2752.05
  • MBI 285.71
  • 52 Week Low
  • FULC $2.32
  • MBI $3.28
  • 52 Week High
  • FULC $8.50
  • MBI $8.26
  • Technical
  • Relative Strength Index (RSI)
  • FULC 59.83
  • MBI 48.68
  • Support Level
  • FULC $6.69
  • MBI $7.32
  • Resistance Level
  • FULC $7.50
  • MBI $7.84
  • Average True Range (ATR)
  • FULC 0.40
  • MBI 0.33
  • MACD
  • FULC 0.07
  • MBI -0.17
  • Stochastic Oscillator
  • FULC 71.38
  • MBI 17.56

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About MBI MBIA Inc.

MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.

Share on Social Networks: